Latest Articles

Publication Date
[Call attention to the reproductive disorders of chronic endometritis].

Chronic endometritis (CE) is an important factor leading to decreased endometrial receptivity, infertility, and repeated pregnancy loss; endometrial immune dysfunction, abnormal microbial flora, inflammatory status, and other factors play important …

Published: Oct. 22, 2024, midnight
Lack of association between the length of anogenital distance and vaginal pH in women with endometriosis.

We investigated the association between the length of anogenital distance (AGD) and intra-vaginal pH, an indicator of vaginal eubiosis or dysbiosis, in women with endometriosis.

Published: Oct. 22, 2024, midnight
Rectal mass: cancer or endometriosis?

Published: Oct. 22, 2024, midnight
Deep Infiltrating Endometriosis Presenting as Large Bowel Obstruction.

Published: Oct. 22, 2024, midnight
P2X4 receptor mediates macrophage infiltration leading to endometriotic cyst epithelium proliferation and hyperalgesia in mouse model.

To evaluate the effects of a P2X4 receptor (P2X4R)-specific antagonist on murine endometriotic-like lesions and human endometriotic stromal cells.

Published: Oct. 22, 2024, midnight
Adenomyosis and Adolescence: A Challenging Diagnosis and Complex Management.

Adenomyosis is a chronic, hormone-related disease characterized by the presence of the endometrial glands and stroma within the myometrium. This condition can manifest in various features, focal or diffuse adenomyosis …

Published: Oct. 22, 2024, midnight
A nomogram model to predict recurrence of early-onset endometrial cancer after resection based on clinical parameters and immunohistochemical markers: A multi-institutional study - Frontiers

A nomogram model to predict recurrence of early-onset endometrial cancer after resection based on clinical parameters and immunohistochemical markers: A multi-institutional study Frontiers

Published: Oct. 21, 2024, 6:48 p.m.
Pembrolizumab aids survival with high-risk endometrial cancer - Medical Xpress

Pembrolizumab aids survival with high-risk endometrial cancer Medical Xpress

Published: Oct. 21, 2024, 5:50 p.m.
Markman’s Take: Vibostolimab in dMMR Endometrial Cancer, Adjuvant Chemo in Cervical Cancer, and More - OncLive

Markman’s Take: Vibostolimab in dMMR Endometrial Cancer, Adjuvant Chemo in Cervical Cancer, and More OncLive

Published: Oct. 21, 2024, 5:04 p.m.
New hope for endometriosis: The revolutionary treatment scientists think might help sufferers - without medication - Daily Mail

New hope for endometriosis: The revolutionary treatment scientists think might help sufferers - without medication Daily Mail

Published: Oct. 21, 2024, 3:59 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!